This is a clinical study to assess the safety, tolerance and immunogenic response to Gardasil
(human papilloma virus (HPV)) and rLP2086 vaccine. Healthy male and female subjects will be
randomized into 1 of 3 groups; the trial will be an observer-blinded study to the injection
being given; and, vaccinated with either Gardasil and rLP2086 concomitantly, rLP2086 and
saline concomitantly, or Gardasil and saline concomitantly. The subjects are adolescent
children between the ages of 11 and 17 years old.